Ceftriaxone: Difference between revisions
Gerald Chi (talk | contribs) m (→Category) |
Gerald Chi (talk | contribs) m (→Overview) |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Ceftriaxone is a third-generation [[cephalosporin]] [[antibiotic]]. Like other third-generation cephalosporins, it has broad spectrum activity against [[Gram positive]] and [[Gram negative]] [[bacteria]]. In most cases, it is considered to be equivalent to [[cefotaxime]] in terms of safety and efficacy. Ceftriaxone sodium is marketed by [[Hoffman-La Roche]] under the [[trade name]] Rocephin. | |||
==Category== | ==Category== | ||
Revision as of 19:09, 31 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
Overview
Ceftriaxone is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram positive and Gram negative bacteria. In most cases, it is considered to be equivalent to cefotaxime in terms of safety and efficacy. Ceftriaxone sodium is marketed by Hoffman-La Roche under the trade name Rocephin.
Category
Cephalosporins, Third-Generation
US Brand Names
CEFTRIAXONE®, ROCEPHIN®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility and Stability | How Supplied | Labels and Packages
References
http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/050796lbl.pdf